LENS - Presbia PLC

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.1299
+0.2099 (+10.9323%)
As of 12:01PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close1.9200
Open2.0045
Bid2.0100 x 200
Ask2.1300 x 100
Day's Range2.0045 - 2.2097
52 Week Range1.8600 - 5.8780
Volume7,014
Avg. Volume12,560
Market Cap36.468M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-1.1510
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
Trade prices are not sourced from all markets
  • Business Wire19 hours ago

    Presbia Announces Board and Management Changes and Financing Proposal to Operate Through to the End of 2018

    Presbia PLC  , an ophthalmic device company and leader in near-vision restoration, announces that it has re-ordered its operational priorities to focus its resources on FDA approval as well as ongoing clinical and commercial efforts in Germany and South Korea.

  • Capital Cube24 days ago

    ETFs with exposure to Presbia Plc : November 21, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Presbia Plc Here are 5 ETFs with the largest exposure to LENS-US. Comparing the performance and risk of Presbia Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Should You Be Holding Presbia PLC (LENS) Right Now?
    Simply Wall St.2 months ago

    Should You Be Holding Presbia PLC (LENS) Right Now?

    For Presbia PLC’s (NASDAQ:LENS) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The beta measures LENS’sRead More...

  • Business Wire3 months ago

    Presbia to Participate in Rodman & Renshaw 19th Annual Global Investment Conference

    Presbia PLC , an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced that Todd Cooper, President and CEO, is scheduled to present at the Rodman & Renshaw 19th Annual Investment Conference.

  • Capital Cube4 months ago

    ETFs with exposure to Presbia Plc : August 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Presbia Plc Here are 5 ETFs with the largest exposure to LENS-US. Comparing the performance and risk of Presbia Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to Presbia Plc : July 3, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Presbia Plc Here are 5 ETFs with the largest exposure to LENS-US. Comparing the performance and risk of Presbia Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to Presbia Plc : June 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Presbia Plc Here are 5 ETFs with the largest exposure to LENS-US. Comparing the performance and risk of Presbia Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Presbia Plc :LENS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
    Capital Cube6 months ago

    Presbia Plc :LENS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017

    Categories: Yahoo FinanceGet free summary analysis Presbia Plc reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Presbia Plc – Tandem Diabetes Care, Inc., Dextera Surgical, Inc. and Ekso Bionics Holdings, Inc. (TNDM-US, DXTR-US and EKSO-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)

  • Business Wire7 months ago

    Presbia to Participate in Jefferies 2017 Global Healthcare Conference

    Presbia PLC , an ophthalmic device company and leader in near-vision restoration that has developed and is currently marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced today that Todd Cooper, President and CEO, is scheduled to present at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6th, at 11:30 a.m.

  • Business Wire7 months ago

    Presbia to Participate in the 2017 ASCRS Symposium & Congress in Los Angeles, California

    Presbia PLC , an ophthalmic device company and leader in near-vision restoration, announced that it will participate in the American Society for Cataract and Refractive Surgery Symposium & Congress, to be held in Los Angeles, California, on May 5 through May 9, 2017.

  • Business Wire9 months ago

    Presbia Announces Completion of Rights Offering

    Presbia PLC , an ophthalmic device company and leader in near-vision restoration, announces the final closing of its rights offering, which expired on March 8, 2017 and raised aggregate gross proceeds of $10.8 million from the sale of 3,611,764 ordinary shares.

  • Business Wire10 months ago

    Presbia Announces Extension of Rights Offering

    Presbia PLC , an ophthalmic device company and leader in near-vision restoration, today announced that it has extended the shareholder rights offering for up to 4,500,000 of its ordinary shares from the previous expiration date of February 23, 2017, until 5:00 p.m., Eastern Time, on Wednesday, March 8, 2017.

  • Business Wire11 months ago

    Presbia Announces Price and Key Dates Related to Rights Offering

    Presbia PLC , an ophthalmic device company and leader in near-vision restoration, announces the key dates relative to its rights offering. Shareholders are advised to ensure they own Presbia’s ordinary shares as of 5 PM ET on February 1, 2017 to be considered a shareholder of record on February 6, 2017.